Page 33 - Platelets News Today

Pacritinib is indicated specifically for patients with myelofibrosis and very low platelet counts, which develop in about one third of patients.

A new study published in the journal Diagnostics provided an overview of ROTEM with a particular focus on interpreting the symmetrical clot formation curve. Researchers also introduced new parameters that could aid in distinguishing between COVID-19 patients and outcomes.

Traumatic injuries are the leading cause of death in the U.S. among people 45 and under, and such injuries account for more than 3 million deaths per year worldwide.

Researchers investigated the role of platelets in the adverse immune response against a COVID-19 vaccine.

Newborns in respiratory failure who require the life-sustaining support of ECMO also require transfusion of red blood cells. But a new study indicates that the higher volume of these oxygen-carrying blood cells the babies receive, the higher their mortality rate.

Mechanical removal of blood clots reduced post-stroke disability in nearly half of "all-comer" real-world stroke patients in an international study, according to preliminary late-breaking science presented today at the American Stroke Association's International Stroke Conference 2022.

Cerebral venous thrombosis is a rare, often severe disease that has been brought to public attention by the Covid 19 pandemic. A research group from Würzburg has now succeeded for the first time in deciphering a molecular cause of this disease.

Researchers report on the potential for serious maternal illness or death during or following a pregnancy complicated by COVID-19.

Blood plays a vital role in keeping us alive, from delivering oxygen to the body’s organs to fighting off infections.

In the case of drugs used for newly diagnosed acute myeloid leukemia (AML), surrogate endpoints have been validated, says the US Food and Drug Administration.